The Opioid Abatement Advisory Commission met today for the first time under its new executive director, Chris Evans, newly elected state treasurer.

Mark Metcalf was also introduced as a new member.

Today's meeting drew an unusually large number of people, with many of them encouraging the commission to move forward with research into ibogaine.

A That's a controversial and illegal psychedelic drug that can be used to treat addiction.

I'm here to encourage you to move forward with ibogaine trials.

There is no silver bullet.

Every case of addiction is different.

It does seem that there is information already suggesting that ibogaine can help alter neuroplasticity enough to give people a fighting chance at meaningful recovery.

And the remarkable results that it's done for traumatic brain injuries for these veterans is unlike anything that we've seen up to this point in medicine.

You don't keep doing the same thing over and over and over and somehow think it's going to turn out better.

It is not.

My son's honest Boston and methadone and treatments, dinners and all of those are great.

They didn't work.

Give him a chance to live.

The Opioid Abatement Advisory Commission is housed under the attorney General's office.

The previous executive director of the commission under former A.G. Daniel Cameron, announced last year that the group was exploring Ibogaine as a possible treatment for opioid use disorder.

Current Attorney General Russell Coleman has said he's concerned the state is not focusing enough on addiction prevention.